Patents Assigned to Universität
  • Patent number: 11674572
    Abstract: The disclosure relates to a drive device (V) for producing a translational motion of a movable tappet (8) by means of an electromagnetic rotating machine. The drive device includes an inner rotor (4) and an outer coaxial stator (5) and has a movement-thread pair integrated coaxially in the stator. The movement-thread pair comprising a lead screw (6), which is coupled to the rotor for conjoint rotation, and a threaded nut (7), which is linearly guided in a stator sleeve (2) in a rotationally fixed manner and is rigidly coupled to the tappet. The rotor is guided for rotation around the stator and a torque being transferred from the rotor to the lead screw by means of a thin-walled flange (10). A rotational fixation (11) of the threaded nut in the cavity of the stator sleeve is provided as a result of interlocking joining of the two.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: June 13, 2023
    Assignee: OTTO-VON-GUERICKE-UNIVERSITAT MAGDEBURG
    Inventors: Denis Draganov, Oleksandr Tyshakin
  • Patent number: 11674640
    Abstract: A safety system is provided for a machine tool which has a frame and a tool. The safety system has a clamping device and a motion device. The clamping device is movable by the motion device from a working position, in which the tool is extended and can be used for working, to a safety position, in which the tool is retracted. The motion device has a first magnetic means connected to or arranged on the tool and a second magnetic means connected to or arranged on the frame, such that movement of the tool by the motion device from the working position to the safety position can be triggered and/or at least partially performed by magnetic force.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: June 13, 2023
    Assignees: Felder KG, Technische Universität Wien
    Inventors: Thomas Weiler, Helmut Caudr, Friedrich Bleicher
  • Patent number: 11674300
    Abstract: The invention relates to a connecting device (3) for mounting a wooden construction element (1), in particular in the form of a panel or beam, on a support (2a), wherein the connecting device (3) has a mounting node (4), which is designed for mounting the connecting device (3) on the support (2a), and a coupling arrangement (5), which is connected to the mounting node (4) and which, in the installed state, while projecting from the mounting node (4) on an upper side (1a) of the wooden construction element (1) can be connected to the latter by fastening members (7), which at least partially pass through the wooden construction element (1), wherein the mounting node (4) and the coupling arrangement (5) are each produced from a material which has a higher strength than that of the wooden construction element (1). The invention further relates to a wooden construction arrangement having a connecting device (3) according to the invention and to a structure having such a wooden construction arrangement.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: June 13, 2023
    Assignee: Universitat Innsbruck
    Inventor: Roland Maderebner
  • Publication number: 20230173113
    Abstract: The invention provides conjugates of cyclic peptides as ligands for cellular surface receptors, in particular, as ligands for ?v?6-integrin. The conjugates further contain effector moieties and are suitable for use as therapeutic agent, diagnostic agent, agent for imaging, targeting moiety and as biomolecular research tool. The invention specifically relates to the use of conjugates with signalling moieties or radionuclides for in-vivo addressing of ?v?6-integrin.
    Type: Application
    Filed: March 12, 2021
    Publication date: June 8, 2023
    Applicant: Technische Universität München
    Inventors: Johannes Notni, Neil Quigley, Katja Steiger
  • Publication number: 20230173102
    Abstract: The invention relates to the use of a recombinant porcine adeno-associated virus (AAV) vector comprising a peptide-modified porcine AAV serotype 1 (AAVpol) capsid in gene therapy of muscle and/or central nervous system (CNS) disorders, in particular neuromuscular diseases such as genetic neuromuscular diseases.
    Type: Application
    Filed: April 28, 2021
    Publication date: June 8, 2023
    Applicants: Genethon, Universität Heidelberg, Universite d'Evry val d'Essonne, Institut National de la Santé et de la Recherche Médicale
    Inventors: Ana Buj Bello, Edith Renaud-Gabardos, Dirk Grimm, Jonas Weinmann
  • Patent number: 11666774
    Abstract: The invention relates to a modular pulse source consisting of a main module and at least one additional module which are connected in series to each other in the sense of two-terminal circuits. The modules each comprise an energy storage device. The energy storage device of the main module is initially charged by a charging circuit. A stimulation coil is connected at the two ends of the series connection and as a result of a voltage pulse delivered by the chain of modules generates a magnetic field which in turn causes an induced electrical pulse or a respective electric field.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: June 6, 2023
    Assignee: Universität der Bundeswehr München
    Inventors: Thomas Weyh, Florian Helling
  • Patent number: 11668636
    Abstract: The particle sensor device comprises a substrate, a photodetector, a dielectric on or above the substrate, a source of electromagnetic radiation, and a through-substrate via in the substrate. The through-substrate via is exposed to the environment, in particular to ambient air. A waveguide is arranged in or above the dielectric so that the electromagnetic radiation emitted by the source of electromagnetic radiation is coupled into a portion of the waveguide. A further portion of the waveguide is opposite the photodetector, so that said portions of the waveguide are on different sides of the through-substrate via, and the waveguide traverses the through-substrate via.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: June 6, 2023
    Assignees: AMS AG, TECHNISCHE UNIVERSITÄT GRAZ
    Inventors: Jochen Kraft, Georg Röhrer, Fernando Jesus Castano Sanchez, Anderson Pires Singulani, Paul Maierhofer
  • Patent number: 11667683
    Abstract: The present invention relates to a polypeptide comprising a silk polypeptide and an antigen. Further, the present invention relates to an article comprising the polypeptide. Furthermore, the present invention relates to a pharmaceutical composition comprising the article. In addition, the present invention relates to the article or pharmaceutical composition for use as a pharmaceutical, for inducing an immune response and/or for use in a prophylactic and/or therapeutic treatment of a disease.
    Type: Grant
    Filed: April 30, 2021
    Date of Patent: June 6, 2023
    Assignees: Amsilk GmbH, Ludwig-Maximilians-Universitat Munchen, Universitat Bayreuth
    Inventors: Lin Romer, Ute Slotta, Julia Engert, Gerhard Winter, Matthias Lucke, Thomas Scheibel
  • Publication number: 20230165879
    Abstract: The present invention relates to a liquisolid pharmaceutical formulation comprising a porous carrier and an active pharmaceutical ingredient loaded onto a surface of the porous carrier, wherein the active pharmaceutical ingredient is dispersed in propylene carbonate or a mixture of propylene carbonate and a further solvent and the dispersion of the active pharmaceutical ingredient and propylene carbonate or a mixture of propylene carbonate and a further solvent is loaded onto the external surface and the internal surface located inside the pores of the porous carrier thereby forming a liquisolid system, and to a process for manufacturing such a liquisolid pharmaceutical formulation.
    Type: Application
    Filed: April 29, 2021
    Publication date: June 1, 2023
    Applicant: RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
    Inventors: Karl G. WAGNER, Alf LAMPRECHT, Anna Katharina KROME, Daris GRISIC, Alexander DENNINGER, Tim BECKER
  • Patent number: 11662354
    Abstract: The invention relates to a method and a computer program for estimating a bilirubin level of a neonate, composed of the steps of: Acquiring a series of bilirubin levels estimated at different time points from a sample obtained from a neonate, Acquiring a plurality of covariates from the neonate, each composed of an information about a neonatal property, Providing a pre-defined bilirubin model function, wherein the bilirubin model function is configured to describe a time course of a bilirubin level of a neonate, Determining a plurality of model parameters of the bilirubin model function, wherein each model parameter is estimated from at least one covariate of the plurality of covariates and an associated population model parameter, Determining from the series of acquired bilirubin levels and the bilirubin model function with the determined model parameters an expected bilirubin level of the neonate for a time particularly later than a lastly acquired bilirubin level of the series of bilirubin levels.
    Type: Grant
    Filed: March 15, 2022
    Date of Patent: May 30, 2023
    Assignee: UNIVERSITÄT BASEL
    Inventors: Gilbert Koch, Sven Wellmann, Marc Pfister, Severin Kasser, Melanie Wilbaux
  • Patent number: 11661676
    Abstract: The invention relates to a method for selecting a sequence set from a library of expressed nucleic acid sequences, wherein cells are provided, each cell comprises an expressed nucleic acid sequence expressed as a target protein. The cells are encapsulated by treating them with a cationic polysaccharide and subsequently treating them with an anionic polysaccharide, yielding encapsulated cells, perforating the membrane of the encapsulated cells, yielding solubilized compartments, contacting them with a ligand to said target protein, the ligand bearing a detectable label, and selecting a subset of solubilized compartments as a function of detectable label and isolating the expressed nucleic acid sequences from the selection as a selected sequence set.
    Type: Grant
    Filed: November 18, 2020
    Date of Patent: May 30, 2023
    Assignee: UNIVERSITÄT ZÜRICH
    Inventors: Daniel Scott, Andreas Plückthun
  • Patent number: 11660824
    Abstract: The invention relates to an apparatus and to a method for establishing a connection having material continuity or having material continuity and shaping matching or for separating such a connection of at least one metal or ceramic component and of a component formed from or by a thermoplastic polymer in which the components to be joined together can be pressed together by a pressing device having a counterholder and a plunger. A heating device is present at the plunger and/or at the counterholder or acts there.
    Type: Grant
    Filed: March 14, 2017
    Date of Patent: May 30, 2023
    Assignees: FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V., TECHNISCHE UNIVERSITAT DRESDEN
    Inventors: Maurice Langer, Annett Klotzbach, Robert Pautzsch
  • Patent number: 11662347
    Abstract: A method for the diagnosis of systemic lupus erythematosus (SLE) based on an interfacial process of antigen-antibody molecular recognition, specifically between anti-Ro52 and Ro52 protein, in a piezoelectric resonator, for application in the diagnosis of autoimmune diseases such as SLE.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: May 30, 2023
    Assignees: UNIVERSITAT POLITECNICA DE VALENCIA, INSTITUTO DE INVESTIGACION SANITARIA LA FE—FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO Y POLITECNICO LA FE DE LA COMUNIDAD VALENCIANA, UNIVERSITAT DE VALENCIA ESTUDI GENERAL
    Inventors: Noelle Marine Do Nascimento, David Gimenez Romero, Sergi Benat Morais Ezquerro, Angel Maquieira Catala, Augusto Miguel Juste Dolz, Elena Grau Garcia, Rosa Puchades Pla, Jose Andres Roman Iborra
  • Publication number: 20230160022
    Abstract: The present invention provides a method for determining the resistance of a microorganism to a drug by detecting at least a transcript of a drug resistance gene from a microorganism in a biological sample, the method comprising the steps of: (i) lysing the cells by means of a chemical or a mechanical method, thereby obtaining a lysate and cell debris; (ii) obtaining a ribosome-antibody complex from the lysate using an antibody or a fragment thereof which binds specifically to a microorganism-ribosomal protein; (iii) purifying the mRNA associated to the ribosome-antibody complex by means of a nucleic acid extraction method; and (iv) submitting the resulting mRNA to a specific gene detection method, thereby identifying the at least one drug resistance gene transcript of the biological sample.
    Type: Application
    Filed: April 11, 2019
    Publication date: May 25, 2023
    Applicant: UNIVERSITAT AUTONOMA DE BARCELONA
    Inventors: Albert QUINTANA ROMERO, Elisenda SANZ IGLESIAS
  • Patent number: 11655293
    Abstract: Described herein is the use of a non-agonist ligand, particularly an antibody, specifically binding to GM-CSF or one of CD116, CD131 and the GM-CSF receptor composed of CD116 and CD131 for use in treatment of leukemia in a patient having undergone allo-HCT or in treatment of other complications arising as a consequence of hematopoietic cell transplantation from an immunologically non-identical donor.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: May 23, 2023
    Assignee: UNIVERSITAT ZURICH
    Inventors: Burkhard Becher, Sonia Tugues
  • Patent number: 11656234
    Abstract: The invention relates to a method and a computer program for estimating a bilirubin level of a neonate, composed of the steps of: Acquiring a series of bilirubin levels estimated at different time points from a sample obtained from a neonate, Acquiring a plurality of covariates from the neonate, each composed of an information about a neonatal property, Providing a pre-defined bilirubin model function, wherein the bilirubin model function is configured to describe a time course of a bilirubin level of a neonate, Determining a plurality of model parameters of the bilirubin model function, wherein each model parameter is estimated from at least one covariate of the plurality of covariates and an associated population model parameter, Determining from the series of acquired bilirubin levels and the bilirubin model function with the determined model parameters an expected bilirubin level of the neonate for a time particularly later than a lastly acquired bilirubin level of the series of bilirubin levels.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: May 23, 2023
    Assignee: UNIVERSITÄT BASEL
    Inventors: Gilbert Koch, Sven Wellmann, Marc Pfister, Severin Kasser, Melanie Wilbaux
  • Patent number: 11655439
    Abstract: A cell culturing system includes a docking station, a handling unit, a culturing module and an actuation layer. The culturing module has a culturing well and a culturing membrane separating the culturing well in an apical culturing chamber and a basal culturing chamber. The handling unit removably accommodates the culturing module and the actuation layer. The docking station has a coupling structure for removably holding the handling unit in a predefined position and an actuation feeding channel, wherein, when the handling unit is held by the coupling structure in the predefined position, a first end of the actuation feeding channel is connected to the actuation bore and a second end of the actuation feeding channel is connected to a connector.
    Type: Grant
    Filed: November 23, 2017
    Date of Patent: May 23, 2023
    Assignees: ALVEOLIX TECHNOLOGIES AG, UNIVERSITÄT BERN
    Inventors: Olivier Thierry Guenat, Janick Daniel Stucki, Marcel Aeschlimann, Christophe Léchot
  • Publication number: 20230152218
    Abstract: An imaging device (110) and a method for imaging at least one object (112), specifically for multispectral imaging or hyperspectral imaging, are disclosed. The imaging device (110) comprises I. at least one image sensor (114) located in at least one image plane (116) of the imaging device (110), the image sensor (114) comprising a plurality of photosensitive elements (118); II. at least one first imaging system (120) configured for generating at least one intermediate image (122) of the object (112) in at least one intermediate image plane (124); III. at least one second imaging system (132) configured for generating at least one image (134) of the intermediate image (122) on the image sensor (114) in the image plane (116); IV. at least one diffractive optical element (142) arranged in the intermediate image plane (124); and V.
    Type: Application
    Filed: October 27, 2022
    Publication date: May 18, 2023
    Applicant: Universität Stuttgart
    Inventors: Tobias Haist, Robin Hahn, Kristina Michel
  • Publication number: 20230152399
    Abstract: A method for preparing an NMR material, comprising generating parahydrogen in gas or liquid form at a first location; transporting the parahydrogen away from the first location; mixing a precursor compound including a metabolite component with a catalyst for hydrogenation; hydrogenating the precursor compound using the parahydrogen; transferring polarization in the precursor compound to a nuclear spin of the metabolite component; cleaving a side arm of the precursor compound in a chemical reaction, with the metabolite molecule being one of the products of the reaction; separating the metabolite molecule from the catalyst for hydrogenation and other products of the reaction; and generating metabolite molecules for use in an MRI scanner by extracting a sample of the metabolite molecule having at least 5% polarization.
    Type: Application
    Filed: March 31, 2021
    Publication date: May 18, 2023
    Applicants: NVISION IMAGING TECHNOLOGIES GMBH, UNIVERSITÄT ULM
    Inventors: Ilai SCHWARTZ, Michael KEIM, Martin PLENIO, Benedikt TRATZMILLER
  • Publication number: 20230151118
    Abstract: The present invention relates to a non-agonist ligand of ARTC1, which inhibits the ADP-ribosyltransferase activity of ARTC1, or an inhibitor nucleic acid sequence capable of downregulating or inhibiting expression of a target nucleic acid sequence encoding ARTC1, for use in prevention or treatment of cancer. The invention also relates to a method for diagnosis of cancer.
    Type: Application
    Filed: April 6, 2021
    Publication date: May 18, 2023
    Applicants: UNIVERSITÄT ZÜRICH, UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF
    Inventors: Friedrich NOLTE, Stephan MENZEL, Tobias SUTER, Michael HOTTIGER, Denise DORVIGNIT-PEDROSO, Jesus GLAUS-GARZON, Kathrin NOWAK, Fabio AIMI